DOI QR코드

DOI QR Code

Plug-Assisted Retrograde Transvenous Obliteration for the Treatment of Gastric Variceal Hemorrhage

  • Chang, Min-Yung (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Man-Deuk (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Taehwan (Department of Radiology, National Health Insurance Serivce Ilsan Hospital) ;
  • Shin, Wonseon (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Shin, Minwoo (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Gyoung Min (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Won, Jong Yun (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Park, Sung Il (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Do Yun (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine)
  • Received : 2015.09.20
  • Accepted : 2015.12.28
  • Published : 2016.04.01

Abstract

Objective: To evaluate the feasibility, safety, and clinical outcomes of plug-assisted retrograde transvenous obliteration (PARTO) to treat gastric variceal hemorrhage in patients with portal hypertension. Materials and Methods: From May 2012 to June 2014, 19 patients (11 men and 8 women, median age; 61, with history of gastric variceal hemorrhage; 17, active bleeding; 2) who underwent PARTO using a vascular plug and a gelfoam pledget were retrospectively analyzed. Clinical and laboratory data were examined to evaluate primary (technical and clinical success, complications) and secondary (worsening of esophageal varix [EV], change in liver function) end points. Median follow-up duration was 11 months, from 6.5 to 18 months. The Wilcoxon signed-rank test was used to compare laboratory data before and after the procedure. Results: Technical success (complete occlusion of the efferent shunt and complete filling of gastric varix [GV] with a gelfoam slurry) was achieved in 18 of 19 (94.7%) patients. The embolic materials could not reach the GV in 1 patient who had endoscopic glue injection before our procedure. The clinical success rate (no recurrence of gastric variceal bleeding) was the same because the technically failed patient showed recurrent bleeding later. Acute complications included fever (n = 2), fever and hypotension (n = 2; one diagnosed adrenal insufficiency), and transient microscopic hematuria (n = 3). Ten patients underwent follow-up endoscopy; all exhibited GV improvement, except 2 without endoscopic change. Five patients exhibited aggravated EV, and 2 of them had a bleeding event. Laboratory findings were significantly improved after PARTO. Conclusion: PARTO is technically feasible, safe, and effective for gastric variceal hemorrhage in patients with portal hypertension.

Keywords

References

  1. Saad WE, Sabri SS. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin Intervent Radiol 2011;28:333-338 https://doi.org/10.1055/s-0031-1284460
  2. de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5:645-663 https://doi.org/10.1016/S1089-3261(05)70186-0
  3. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343-1349 https://doi.org/10.1002/hep.1840160607
  4. Lee CH, Lee JH, Choi YS, Paik SW, Sinn DH, Lee CY, et al. [Natural history of gastric varices and risk factors for bleeding]. Korean J Hepatol 2008;14:331-341 https://doi.org/10.3350/kjhep.2008.14.3.331
  5. Rosolowski M, Hartleb M, Marek T, Milewski J, Linke K, Wallner G, et al. Therapeutic and prophylactic management of bleeding from oesophageal and gastric varices-recommendations of the Working Group of the National Consultant for Gastroenterology. Prz Gastroenterol 2014;9:63-68
  6. Triantafyllou M, Stanley AJ. Update on gastric varices. World J Gastrointest Endosc 2014;6:168-175 https://doi.org/10.4253/wjge.v6.i5.168
  7. Saad WE, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin Intervent Radiol 2011;28:339-349 https://doi.org/10.1055/s-0031-1284461
  8. Park SJ, Chung JW, Kim HC, Jae HJ, Park JH. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. J Vasc Interv Radiol 2010;21:503-507 https://doi.org/10.1016/j.jvir.2009.11.023
  9. Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology 1999;211:349-356 https://doi.org/10.1148/radiology.211.2.r99ma25349
  10. Lee JY, Moon SH, Lee SM, Kim HT, Uh S, Kim YH, et al. A case of noncardiogenic pulmonary edema by ethanolamine oleate. Korean J Intern Med 1994;9:125-127 https://doi.org/10.3904/kjim.1994.9.2.125
  11. Uchibori S. [Pulmonary circulatory disturbance following endoscopic injection sclerotherapy]. Nihon Kyobu Shikkan Gakkai Zasshi 1993;31:833-839
  12. Patel A, Fischman AM, Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices. AJR Am J Roentgenol 2012;199:721-729 https://doi.org/10.2214/AJR.12.9052
  13. Gwon DI, Ko GY, Yoon HK, Sung KB, Kim JH, Shin JH, et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration--a primary report. Radiology 2013;268:281-287 https://doi.org/10.1148/radiol.13122102
  14. Gwon DI, Kim YH, Ko GY, Kim JW, Ko HK, Kim JH, et al. Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study. J Vasc Interv Radiol 2015;26:1589-1595 https://doi.org/10.1016/j.jvir.2015.07.011
  15. Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 2010;22:1-9 https://doi.org/10.1111/j.1443-1661.2009.00929.x
  16. Akahoshi T, Tomikawa M, Kamori M, Tsutsumi N, Nagao Y, Hashizume M, et al. Impact of balloon-occluded retrograde transvenous obliteration on management of isolated fundal gastric variceal bleeding. Hepatol Res 2012;42:385-393 https://doi.org/10.1111/j.1872-034X.2011.00939.x
  17. Ninoi T, Nishida N, Kaminou T, Sakai Y, Kitayama T, Hamuro M, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol 2005;184:1340-1346 https://doi.org/10.2214/ajr.184.4.01841340
  18. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001;12:327-336 https://doi.org/10.1016/S1051-0443(07)61912-5
  19. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988;2:340-341
  20. Cho SK, Shin SW, Lee IH, Do YS, Choo SW, Park KB, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol 2007;189:W365-W372 https://doi.org/10.2214/AJR.07.2266
  21. Cho SK, Shin SW, Do YS, Park KB, Choo SW, Kim SS, et al. Development of thrombus in the major systemic and portal veins after balloon-occluded retrograde transvenous obliteration for treating gastric variceal bleeding: its frequency and outcome evaluation with CT. J Vasc Interv Radiol 2008;19:529-538 https://doi.org/10.1016/j.jvir.2007.10.012
  22. Lee EW, Saab S, Gomes AS, Busuttil R, McWilliams J, Durazo F, et al. Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results. Clin Transl Gastroenterol 2014;5:e61 https://doi.org/10.1038/ctg.2014.12
  23. Shimoda R, Horiuchi K, Hagiwara S, Suzuki H, Yamazaki Y, Kosone T, et al. Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts. Abdom Imaging 2005;30:306-313 https://doi.org/10.1007/s00261-004-0270-8
  24. Sonomura T, Ono W, Sato M, Sahara S, Nakata K, Sanda H, et al. Three benefits of microcatheters for retrograde transvenous obliteration of gastric varices. World J Gastroenterol 2012;18:1373-1378 https://doi.org/10.3748/wjg.v18.i12.1373
  25. Sonomura T, Ono W, Sato M, Sahara S, Nakata K, Sanda H, et al. Emergency balloon-occluded retrograde transvenous obliteration of ruptured gastric varices. World J Gastroenterol 2013;19:5125-5130 https://doi.org/10.3748/wjg.v19.i31.5125
  26. Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol 2003;4:109-116 https://doi.org/10.3348/kjr.2003.4.2.109
  27. Khawaja A, Sonawalla AA, Somani SF, Abid S. Management of bleeding gastric varices: a single session of histoacryl injection may be sufficient. Eur J Gastroenterol Hepatol 2014;26:661-667
  28. Saad WE, Wagner CC, Lippert A, Al-Osaimi A, Davies MG, Matsumoto AH, et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol 2013;108:1612-1619 https://doi.org/10.1038/ajg.2013.232
  29. Saad WE, Wagner CC, Al-Osaimi A, Bliebel W, Lippert A, Davies MG, et al. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores. Vasc Endovascular Surg 2013;47:281-287 https://doi.org/10.1177/1538574413485646
  30. Kumamoto M, Toyonaga A, Inoue H, Miyakoda K, Morita Y, Emori K, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol 2010;25:1129-1135 https://doi.org/10.1111/j.1440-1746.2010.06262.x

Cited by

  1. Endovascular Treatment of Pelvic Congestion Syndrome Using Vascular Plug vol.57, pp.12, 2016, https://doi.org/10.7133/jca.17-00022
  2. Long-Term Outcomes of Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: A Comparison of Ethanolamine Oleate and Sodium Tetradecyl Sulfate vol.41, pp.4, 2016, https://doi.org/10.1007/s00270-017-1869-9
  3. Modified Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Techniques for the Treatment of Gastric Varices: Vascular Plug-Assisted Retrograde Transvenous Obliteration (PARTO)/Coil-Assisted R vol.41, pp.6, 2016, https://doi.org/10.1007/s00270-018-1896-1
  4. Plug-Assisted Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: The Role of Intra-Procedural Cone-Beam Computed Tomography vol.19, pp.2, 2018, https://doi.org/10.3348/kjr.2018.19.2.223
  5. Management Options for Gastric Variceal Hemorrhage vol.154, pp.6, 2016, https://doi.org/10.1001/jamasurg.2019.0407
  6. The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage vol.32, pp.5, 2016, https://doi.org/10.1097/meg.0000000000001705
  7. Endoscopic ‘hybrid’ treatments for gastric varices: Do we need belt and suspenders? vol.8, pp.2, 2016, https://doi.org/10.1055/a-1024-3852
  8. Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration vol.14, pp.6, 2016, https://doi.org/10.5009/gnl19293
  9. Friend or Foe? Spontaneous Portosystemic Shunts in Cirrhosis-Current Understanding and Future Prospects vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/8795115
  10. Balloon-occluded Retrograde Transvenous Obliteration Versus Transjugular Intrahepatic Portosystemic Shunt for Gastric Varices : A Meta-Analysis vol.55, pp.2, 2016, https://doi.org/10.1097/mcg.0000000000001305
  11. Halting the haematochezia vol.12, pp.3, 2016, https://doi.org/10.1136/flgastro-2020-101495
  12. Endovascular Management of Hepatic Encephalopathy vol.5, pp.2, 2016, https://doi.org/10.1055/s-0041-1730869
  13. Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective study vol.76, pp.9, 2021, https://doi.org/10.1016/j.crad.2021.05.011